MASON WADE: Open Payments
NPI 1629534656 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,151 in 51 payments from 6 companies in 2025. Trend: 2023 $765 · 2024 $4,420 · 2025 $1,151
Food & beverage: $1,151
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 27 | $584 |
| ViiV Healthcare Company | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 3 | $181 |
| Merck Sharp & Dohme LLC | 6 | $109 |
| ABBVIE INC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $13 |
Products named: FARXIGA, DOVATO, PIFELTRO, Epclusa, RUKOBIA, Biktarvy, MAVYRET, Cologuard Collection Kit.
Industry payments across AL — which companies pay providers there.
